Cognitive frailty is a heterogeneous clinical manifestation characterized by the simultaneous presence of both physical frailty and cognitive impairment, in the absence of dementia, and it seems to entail a greater death risk than physical frailty or cognitive impairment separately.
Prolong your life by increasing your muscle power. That’s the main message of a study presented at EuroPrevent 2019, a congress of the European Society of Cardiology.
Researchers have known for decades that inflammation accompanies Alzheimer’s disease (AD) brain lesions. Several early studies suggested that “super-aspirins” or Nonsteroidal anti-inflammatory drugs (NSAID) could help avoid the disease. However, after clinical trials showed that NSAIDs don’t help patients who already have AD symptoms, doctors wondered whether these drugs could still be helpful to people who were at risk of developing the disease, but weren’t yet showing symptoms.
As people get older, the more likely they are to take several different medicines on a regular basis. However, this increases the risk of adverse effects, including interactions between the various active agents. Electronic decision-support tools for doctors are a possible solution but patients themselves can also help, Andreas Sönnichsen points out, Professor of Family Medicine at MedUni Vienna, speaking on the occasion of the World Health Day on 7 April.
Older men tend to have lower biological age if they have higher levels of sex hormones, particularly the estradiol form of estrogen, a large new study from Australia finds. The study results will be presented on Sunday at ENDO 2019, the Endocrine Society’s annual meeting in New Orleans, La., and appear online in the journal Clinical Endocrinology.
Dementia risk in mid-life patients with atrial fibrillation (AF) can be reduced by controlling high blood pressure, according to a study presented at EHRA 2019, a congress of the European Society of Cardiology (ESC).